PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-40.37%
Negative revenue growth while 8198.HK stands at 2190.44%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
4.11%
Positive gross profit growth while 8198.HK is negative. John Neff would see a clear operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
331.61%
Positive operating income growth while 8198.HK is negative. John Neff might view this as a competitive edge in operations.
122.84%
Positive net income growth while 8198.HK is negative. John Neff might see a big relative performance advantage.
123.08%
Positive EPS growth while 8198.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
123.08%
Positive diluted EPS growth while 8198.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-1.87%
Share reduction while 8198.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.87%
Reduced diluted shares while 8198.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-52.62%
Negative OCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-52.45%
Negative FCF growth while 8198.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-28.92%
Negative 10Y revenue/share CAGR while 8198.HK stands at 0.00%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-28.39%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
5.64%
Positive 3Y CAGR while 8198.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
782.75%
OCF/share CAGR of 782.75% while 8198.HK is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
157.26%
Positive OCF/share growth while 8198.HK is negative. John Neff might see a comparative advantage in operational cash viability.
104.13%
Positive 3Y OCF/share CAGR while 8198.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-68.71%
Negative 10Y net income/share CAGR while 8198.HK is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-46.68%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-57.80%
Negative 3Y CAGR while 8198.HK is 22.20%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
6.34%
Below 50% of 8198.HK's 227.16%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.80%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while 8198.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-100.00%
Negative near-term dividend growth while 8198.HK invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-37.69%
Firm’s AR is declining while 8198.HK shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-50.48%
Inventory is declining while 8198.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-41.20%
Negative asset growth while 8198.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.14%
BV/share growth of 2.14% while 8198.HK is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-70.86%
We’re deleveraging while 8198.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-33.26%
We cut SG&A while 8198.HK invests at 43.38%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.